Skip to main content
. 2017 Feb 24;8(12):20244–20251. doi: 10.18632/oncotarget.15666

Figure 3. The expression of ACE, AT1R, ACE2 and MasR mRNA in hypothalamus and pituitary of SHR compared with WKY.

Figure 3

Note: A: the expression of ACE, AT1A, ACE2 and MasR mRNA in SHR hypothalamus compared with that of WKY group, * P<0.05; B: the expression of ACE, AT1B, ACE2 and MasR mRNA in SHR pituitary compared with that of WKY group, * P<0.05.